| Q51749027 | A comparative approach to strategies for cloning, expression, and purification of Mycobacterium tuberculosis mycolyl transferase 85B and evaluation of immune responses in BALB/c mice. |
| Q37137882 | Antibody-mediated immunity against tuberculosis: implications for vaccine development |
| Q36238031 | B cells and antibodies in the defense against Mycobacterium tuberculosis infection |
| Q37477387 | Bacterial polyester inclusions engineered to display vaccine candidate antigens for use as a novel class of safe and efficient vaccine delivery agents. |
| Q36811028 | CBA/J mice generate protective immunity to soluble Ag85 but fail to respond efficiently to Ag85 during natural Mycobacterium tuberculosis infection |
| Q31028998 | Cellular immune responses to nine Mycobacterium tuberculosis vaccine candidates following intranasal vaccination |
| Q37844882 | Development of vaccines against tuberculosis |
| Q59798720 | Dual-Isotope SPECT/CT Imaging of the Tuberculosis Subunit Vaccine H56/CAF01: Induction of Strong Systemic and Mucosal IgA and T-Cell Responses in Mice Upon Subcutaneous Prime and Intrapulmonary Boost Immunization |
| Q36237421 | Evaluation of Humoral Immunity to Mycobacterium tuberculosis-Specific Antigens for Correlation with Clinical Status and Effective Vaccine Development. |
| Q58827716 | Immunological and physical evaluation of the multistage tuberculosis subunit vaccine candidate H56/CAF01 formulated as a spray-dried powder |
| Q37862987 | Immunological biomarkers of tuberculosis |
| Q27332450 | Influence of maternal gestational treatment with mycobacterial antigens on postnatal immunity in an experimental murine model |
| Q51964364 | Intratracheal administration of third-generation lentivirus vector encoding MPT51 from Mycobacterium tuberculosis induces specific CD8+ T-cell responses in the lung. |
| Q42417060 | Investigations of TB vaccine-induced mucosal protection in mice. |
| Q42256538 | Mucosal delivery of antigen-coated nanoparticles to lungs confers protective immunity against tuberculosis infection in mice |
| Q58587624 | Mycobacterium Tuberculosis and Interactions with the Host Immune System: Opportunities for Nanoparticle Based Immunotherapeutics and Vaccines |
| Q37454755 | Mycobacterium avium MAV2054 protein induces macrophage apoptosis by targeting mitochondria and reduces intracellular bacterial growth. |
| Q35164284 | Role of B cells and antibodies in acquired immunity against Mycobacterium tuberculosis |
| Q37552026 | The protective role of antibody responses during Mycobacterium tuberculosis infection |
| Q92857461 | Tuberculosis vaccine candidates based on mycobacterial cell envelope components |
| Q31156691 | Whole genome identification of Mycobacterium tuberculosis vaccine candidates by comprehensive data mining and bioinformatic analyses |